1. Home
  2. PTIX vs XPON Comparison

PTIX vs XPON Comparison

Compare PTIX & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • XPON
  • Stock Information
  • Founded
  • PTIX 1994
  • XPON 2016
  • Country
  • PTIX United States
  • XPON United States
  • Employees
  • PTIX N/A
  • XPON N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • XPON Electronic Components
  • Sector
  • PTIX Health Care
  • XPON Technology
  • Exchange
  • PTIX Nasdaq
  • XPON Nasdaq
  • Market Cap
  • PTIX 2.0M
  • XPON 1.9M
  • IPO Year
  • PTIX 2016
  • XPON 2022
  • Fundamental
  • Price
  • PTIX $0.27
  • XPON $1.44
  • Analyst Decision
  • PTIX
  • XPON
  • Analyst Count
  • PTIX 0
  • XPON 0
  • Target Price
  • PTIX N/A
  • XPON N/A
  • AVG Volume (30 Days)
  • PTIX 599.7K
  • XPON 101.8K
  • Earning Date
  • PTIX 03-31-2025
  • XPON 03-27-2025
  • Dividend Yield
  • PTIX N/A
  • XPON N/A
  • EPS Growth
  • PTIX N/A
  • XPON N/A
  • EPS
  • PTIX N/A
  • XPON N/A
  • Revenue
  • PTIX N/A
  • XPON $4,498,181.00
  • Revenue This Year
  • PTIX N/A
  • XPON N/A
  • Revenue Next Year
  • PTIX N/A
  • XPON $66.62
  • P/E Ratio
  • PTIX N/A
  • XPON N/A
  • Revenue Growth
  • PTIX N/A
  • XPON N/A
  • 52 Week Low
  • PTIX $0.25
  • XPON $1.32
  • 52 Week High
  • PTIX $1.87
  • XPON $418.00
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 34.94
  • XPON 41.61
  • Support Level
  • PTIX $0.25
  • XPON $1.33
  • Resistance Level
  • PTIX $0.30
  • XPON $1.53
  • Average True Range (ATR)
  • PTIX 0.03
  • XPON 0.08
  • MACD
  • PTIX 0.00
  • XPON 0.03
  • Stochastic Oscillator
  • PTIX 10.43
  • XPON 57.97

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About XPON Expion360 Inc.

Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.

Share on Social Networks: